Form D — NEXT Life Sciences Inc Dec 2024 a Series of CGF2021 LLC
0002056196-25-000001 · filed 2025-02-14
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1
- Total offering
- $259,143
- Total sold
- $259,143
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NEXT Life Sciences Inc Dec 2024 a Series of CGF2021 LLC
- CIK
- 2056196
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2093 PHILADELPHIA PIKE
CLAYMONT, DE 19703 - Phone
- (360) 946-0604
Related persons
-
LLC Sydecar · DirectorClaymont, DE
-
Brett Sagan · Executive OfficerClaymont, DE
View original on SEC EDGAR.